P1.01-72 FIND Trial: A Phase II Study to Evaluate the Efficacy of the FGFR-Inhibitor Erdafitinib in FGFR-Mutated and -Translocated Squamous NSCLC

JOURNAL OF THORACIC ONCOLOGY(2018)

引用 2|浏览48
暂无评分
关键词
FGFR mutations/translocations,advanced sqNSCLC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要